John Patrick Sanchez is a pharmacist who is specialized in Oncology in Houston, Texas. Patients can reach him at 1515 Holcombe Blvd Unit 90, Houston or contact him on 281-794-1697. Active license number of John Patrick Sanchez is 6026 for Oncology in Texas. John Patrick Sanchez is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
John Patrick Sanchez speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
John Patrick Sanchez
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
1515 Holcombe Blvd Unit 90, Houston, Texas, 77030-4000
Phone:
281-794-1697
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of John Patrick Sanchez are as mentioned below.
NPI Number:
1992330674
NPI Enumeration Date:
03 Mar, 2020
NPI Last Update On:
03 Mar, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for John Patrick Sanchez are as mentioned below.
Specialization
License Number
State
Status
Oncology
6026
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1515 Holcombe Blvd Unit 90, Houston, Texas
Zip:
77030-4000
Phone Number:
--
Fax Number:
--
Patients can reach John Patrick Sanchez at 1515 Holcombe Blvd Unit 90, Houston, Texas or can call on phone at 281-794-1697.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.